Clopidogrel is not an anticoagulant; it is an antiplatelet medication [1].
How Do Antiplatelets and Anticoagulants Differ?
Antiplatelets work by preventing blood platelets from clumping together and forming blood clots [2]. Anticoagulants, on the other hand, work by slowing down the body's clotting process itself, affecting various clotting factors in the blood [2]. While both types of drugs help prevent blood clots, they do so through different mechanisms and are used for different conditions [2].
What Conditions Does Clopidogrel Treat?
Clopidogrel is prescribed to help prevent blood clots in individuals who have experienced a recent heart attack, stroke, or have peripheral artery disease [1]. It is often used in combination with aspirin for patients with acute coronary syndrome or after certain procedures like stent placement [1].
How Does Clopidogrel Work?
Clopidogrel functions by irreversibly blocking a specific receptor on platelets, known as the P2Y12 receptor [3]. This blockage inhibits adenosine diphosphate (ADP), a substance that promotes platelet aggregation, thereby reducing the likelihood of clot formation [3].
When Does Clopidogrel Patent Exclusivity Expire?
Information on the specific patent expiry for clopidogrel formulations can be found on DrugPatentWatch.com [4]. Patent expirations are crucial as they pave the way for generic competition, potentially leading to lower medication costs [4].